Hyperprolactinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} | |||
{{Hyperprolactinemia}} | |||
{{SK}} Hyperprolactinaemia; Ahumada-DelCastillo syndrome; Chiari-Frommel syndrome; Forbes-Albright syndrome | |||
'''For patient information click [[Hyperprolactinaemia (patient information)|here]]''' | '''For patient information click [[Hyperprolactinaemia (patient information)|here]]''' | ||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = Hyperprolactinemia | | Name = Hyperprolactinemia | | ||
| Line 13: | Line 19: | ||
MeshID = D006966 | | MeshID = D006966 | | ||
}} | }} | ||
==[[Hyperprolactinemia overview|Overview]]== | |||
==[[Hyperprolactinemia historical perspective|Historical Perspective]]== | |||
==[[Hyperprolactinemia classification|Classification]]== | |||
==[[Hyperprolactinemia pathophysiology|Pathophysiology]]== | |||
==[[Hyperprolactinemia causes|Causes]]== | |||
==[[Hyperprolactinemia differential diagnosis|Differentiating Hyperprolactinemia from other Diseases]]== | |||
==[[Hyperprolactinemia epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Hyperprolactinemia risk factors|Risk Factors]]== | |||
==[[Hyperprolactinemia screening|Screening]]== | |||
== | ==[[Hyperprolactinemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
== | ==Diagnosis== | ||
[[Hyperprolactinemia history and symptoms|History and Symptoms]] | [[Hyperprolactinemia physical examination|Physical Examination]] | [[Hyperprolactinemia laboratory findings|Laboratory Findings]] | [[Hyperprolactinemia electrocardiogram|Electrocardiogram]] | [[Hyperprolactinemia CT|CT]] | [[Hyperprolactinemia MRI|MRI]] | [[Hyperprolactinemia echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Hyperprolactinemia other imaging findings|Other Imaging Findings]] | [[Hyperprolactinemia other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Hyperprolactinemia medical therapy|Medical Therapy]] | [[Hyperprolactinemia surgery|Surgery]] | [[Hyperprolactinemia primary prevention|Primary Prevention]] | [[Hyperprolactinemia secondary prevention|Secondary Prevention]] | [[Hyperprolactinemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hyperprolactinemia future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Hyperprolactinemia case study one|Case #1]] | |||
==Acknowledgements== | |||
{{ | The content on this page was first contributed by: C. Michael Gibson, M.S., M.D. | ||
==References== | |||
{{reflist|2}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 11:47, 27 July 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
|
Hyperprolactinemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyperprolactinemia On the Web |
|
American Roentgen Ray Society Images of Hyperprolactinemia |
Synonyms and keywords: Hyperprolactinaemia; Ahumada-DelCastillo syndrome; Chiari-Frommel syndrome; Forbes-Albright syndrome
For patient information click here
| Hyperprolactinemia | |
| ICD-10 | E22.1 |
|---|---|
| ICD-9 | 253.1 |
| DiseasesDB | 6314 |
| MeSH | D006966 |
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hyperprolactinemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.